Reflections of a cancer scientist

Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

What inspires us? What gets us excited? What causes us to devote our life to a cause?

The unknown, a hope for better options, the drive to discover.

Example?

Look at where our understanding of cancer was two, five, 10, 15, 20, or more years ago and then consider what has happened over the past two decades. We finally realized how more complex the problem of cancer is—more than any of us imagined. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center
Table of Contents

YOU MAY BE INTERESTED IN

Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login